Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital

por Asgeirsson, Hilmir, Thalme, Anders, Weiland, Ola
Publicado 2016

Reduced work absenteeism in patients with hepatitis C treated with second‐generation direct‐acting antivirals

por Lindgren, Peter, Löfvendahl, Sofia, Brådvik, Gunnar, Weiland, Ola
Publicado 2020

Low Levels of Microbial Translocation Marker LBP Are Associated with Sustained Viral Response after Anti-HCV Treatment in HIV-1/HCV Co-Infected Patients

por Nyström, Jessica, Stenkvist, Jenny, Häggblom, Amanda, Weiland, Ola, Nowak, Piotr
Publicado 2015

Value appropriation in hepatitis C

por Lindgren, Peter, Löfvendahl, Sofia, Brådvik, Gunnar, Weiland, Ola, Jönsson, Bengt
Publicado 2021

The Dynamic Relationship between Innate Immune Biomarkers and Interferon-Based Treatment Effects and Outcome in Hepatitis C Virus Infection Is Altered by Telaprevir

por Malone, David F. G., Falconer, Karolin, Weiland, Ola, Sandberg, Johan K.
Publicado 2014

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations

por Lagging, Martin, Wejstål, Rune, Norkrans, Gunnar, Karlström, Olle, Aleman, Soo, Weiland, Ola, Castedal, Maria, Josephson, Filip
Publicado 2016

Impact of IL28B-Related Single Nucleotide Polymorphisms on Liver Transient Elastography in Chronic Hepatitis C Infection

por Ydreborg, Magdalena, Westin, Johan, Rembeck, Karolina, Lindh, Magnus, Norrgren, Hans, Holmberg, Anna, Wejstål, Rune, Norkrans, Gunnar, Cardell, Kristina, Weiland, Ola, Lagging, Martin
Publicado 2013

Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C

por Weiland, Ola, Ahlén, Gustaf, Diepolder, Helmut, Jung, Maria-Christina, Levander, Sepideh, Fons, Michael, Mathiesen, Iacob, Sardesai, Niranjan Y, Vahlne, Anders, Frelin, Lars, Sällberg, Matti
Publicado 2013

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study

por Borssén, Åsa D., Palmqvist, Richard, Kechagias, Stergios, Marschall, Hanns-Ulrich, Bergquist, Annika, Rorsman, Fredrik, Weiland, Ola, Verbaan, Hans, Nyhlin, Nils, Nilsson, Emma, Werner, Mårten
Publicado 2017

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

por Young, Jim, Weis, Nina, Hofer, Harald, Irving, William, Weiland, Ola, Giostra, Emiliano, Pascasio, Juan Manuel, Castells, Lluis, Prieto, Martin, Postema, Roelien, Lefevre, Cinira, Evans, David, Bucher, Heiner C., Calleja, Jose Luis
Publicado 2017

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world...

por Welzel, Tania M, Petersen, Jörg, Herzer, Kerstin, Ferenci, Peter, Gschwantler, Michael, Wedemeyer, Heiner, Berg, Thomas, Spengler, Ulrich, Weiland, Ola, van der Valk, Marc, Rockstroh, Jürgen, Peck-Radosavljevic, Markus, Zhao, Yue, Jimenez-Exposito, Maria Jesus, Zeuzem, Stefan
Publicado 2016

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study

por Dalgard, Olav, Weiland, Ola, Noraberg, Geir, Karlsen, Lars, Heggelund, Lars, Färkkilâ, Martti, Balslev, Ulla, Belard, Erika, Øvrehus, Anne, Skalshøi Kjær, Mette, Krarup, Henrik, Thorup Røge, Birgit, Hallager, Sofie, Madsen, Lone G., Lund Laursen, Alex, Lagging, Martin, Weis, Nina
Publicado 2017

Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis

por Flamm, Steven, Mutimer, David, Asatryan, Armen, Wang, Stanley, Rockstroh, Jürgen, Horsmans, Yves, Kwo, Paul Y., Weiland, Ola, Villa, Erica, Heo, Jeong, Gane, Edward, Ryder, Stephen D., Welzel, Tania M., Ruane, Peter J., Agarwal, Kosh, Ng, Teresa I., Xue, Zhenyi, Lovell, Sandra S., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Trinh, Roger, Mensa, Federico J., Wyles, David L.
Publicado 2018